'The De Novo request provides a marketing pathway to classify novel medical devices for which general controls alone, or general and special controls, provide reasonable assurance of safety and effectiveness for the intended use, but for which there is no legally marketed predicate device.4 Oct 2022.'
Ann: Optiscan Intends to pursue De Novo Pathway for InVivage, page-39
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $125.3M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $22.24K | 149.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 91022 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 700 | 1 |
View Market Depth
| Last trade - 15.38pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
14.5¢ |
Change
-0.005 ( 6.45 %) |
||||
| Open | High | Low | Volume | ||
| 14.5¢ | 14.5¢ | 14.5¢ | 12503 | ||
| Last updated 12.17pm 14/06/2024 ? | |||||
| OIL (ASX) Chart |